ReviewBreast care (Basel, Switzerland)2017

PI3K/mTOR Inhibitors in the Treatment of Luminal Breast Cancer. Why, When and to Whom?

Francesco Schettini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.